B. Mark Evers, M.D., is the director of the UK's Markey Cancer Center, physician in chief of oncology service and a professor of surgery in the UK College of Medicine. Markey is 1 of only 72 National Cancer Institute-Designated Comprehensive Cancer Centers in the country. It’s the first and only center in Kentucky to achieve this designation.
Katherine Hartmann, M.D., Ph.D., is the director of the UK Center for Clinical and Translational Science (CCTS) and a professor of obstetrics and gynecology in the UK College of Medicine. CCTS’ goal is to deliver solutions for researchers across UK’s 16 colleges and UK HealthCare. It is currently funded by a prestigious award from the National Center for Advancing Translational Sciences (NCATS).
The National Institutes of Health (NIH) support research at the University of Kentucky in a variety of ways — from individual grants to supports for centers and graduate students. Acting Vice President for Research Ilhem Messaoudi offers a breakdown of this support as part of a recent video campaign from Research Communications.
Greg Jicha, M.D., Ph.D., is supported by the NIH’s National Institute on Aging, which leads research on aging, the aging process and diseases and conditions associated with growing older, in order to extend the healthy, active years of life.
LEXINGTON, Ky. (April 28, 2025) — The University of Kentucky plays a critical role in advancing the health, well-being and future of the Commonwealth through impactful research. As Kentucky’s flagship, land-grant institution, UK focuses its resources, expertise and key partnerships to address the challenges facing our state to improve the quality of life for Kentuckians.
LEXINGTON, Ky. (April 24, 2025) — A comprehensive new review by researchers at the University of Kentucky sheds light on the intricate and damaging relationship between obesity and kidney disease. The review, recently published in the prestigious Nature Reviews Nephrology, details the multiple ways in which excess fat tissue disrupts kidney function and even triggers changes in the brain that further exacerbate renal damage. Conversely, when the kidneys aren’t working properly, that can also affect adipose tissue (or body fat).